Precision, purity & performance (1-3) Evolving with Nuceiva® (prabotulinumtoxinA).
Ever wondered what difference the manufacturing process makes to the clinical outcomes of a toxin? Hear about HI-PURETM technology and the clinical outcomes Dr David Eccleston has seen with Nuceiva®.
An interactive session enabling you to get up close and personal with the new kid on the block, Nuceiva® (prabotulinumtoxinA) a neuromodulator designed for precision (1), delivering targeted results (4,5) with high purity (1,2).
Chat with the incredible Dr David Eccleston as he takes you on a tour through:
✅ the power of precise technique (4,5) in facial aesthetics and how Nuceiva® supports accuracy in injection
✅ the science behind the manufacturing of Nuceiva®, a toxin designed for precision (1) using patented HI-PURE technology (1,2)
✅ the performance of Nuceiva® in real life case studies spanning multiple treatments.
This webinar will help you understand the manufacturing process & science behind Nuceiva® and how that applies to your linical practice.
Daewoong Method for production of botulinum toxin. Accessed May 2024. https://patents.google.com/patent/US9512418B2/en
Hi-Pure Technology 2013 Trademark of Daewoong Co., Ltd.
Rzany BJ, et al. Aesthet Surg J. 2020;40(4):413-429
NUCEIVA® Product Information
Kaminer MS, et al. J Drugs Dermatol. 2020;19(4):s5-15
Speaker: Dr David Eccleston
Dr David Eccleston is the Clinical Director of MediZen, founded in 1999 along with his wife Annie, a registered nurse. He was one of the first doctors in the country to offer cosmetic injectables, and his experience has led him to be recognised as ‘Aesthetic Doctor of the Year‘ and Tatler’s ‘Man in the Midlands‘. He has also appeared in and authored many magazine articles, and taken part in television and radio interviews on the subject of non-surgical medical aesthetics. He has featured multiple times in the UK press, namely as one of the UK’s top 10 Anti-Wrinkle Doctors in the feature; ‘Superstars of the Aesthetic World’.
Dr Eccleston is an International Key Opinion Leader in the specialty. He is a Faculty Member of the International ACE Complications Group, and he was awarded the ‘Lifetime Achievement Award’ at the 2023 Safety In Beauty Awards for his valued contribution to the aesthetics specialty over the past 25 years. These awards champion those who go the extra mile to keep the public safe from rogue and unscrupulous practitioners, and commends “special candidates who have displayed extraordinary dedication to raising awareness and standards in the beauty, health and aesthetics field.”
David has nearly 30 years of experience using anti-wrinkle injections and dermal fillers. He first developed an interest in Cosmetic Dermatology in 1993, whilst working as an NHS GP, and received personal training from worldwide experts in the field, including Professor Jean Carruthers, the Canadian doctor credited with first identifying the potential for anti-wrinkle injections as an aesthetic treatment in the late 1980s. Every practitioner at MediZen has been personally trained and mentored by Dr Eccleston, so you can be sure that whoever you see at MediZen, you will receive only the highest quality treatment.
He is the only medical practitioner in the UK to have been a lead investigator in clinical trials on the first UK licensed brands of anti-wrinkle injections, and continues to have an active research interest. He also works closely as an advisor and trainer with several major aesthetic product and equipment providers, such as Cutera Lasers, DermaFocus, AlumierMD Medical Skincare, Allergan and Evolus.
David is in great demand as an international trainer, and has educated over 10,000 practitioners all over the world, travelling to Australia, the USA, Canada, South Africa, Europe and the Middle East, teaching and mentoring practitioners on the safe and correct use of anti-wrinkle injectables and dermal fillers, a subject about which he is extremely passionate. This led him to found his own training centre in Sutton Coldfield, ‘The MediZen Academy‘.